Jennison Associates’s Edwards Lifesciences EW Stock Holding History

Jennison Associates’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05B	Sell	13,066,274 -714,241	-5%	-$58.9M	0.72%	32
2025 Q4	$1.17B	Sell	13,780,515 -178,259	-1%	-$14.6M	0.71%	34
2025 Q3	$1.09B	Buy	13,958,774 +2,287,783	+20%	+$179M	0.63%	34
2025 Q2	$913M	Buy	11,670,991 +1,584,958	+16%	+$118M	0.54%	36
2025 Q1	$731M	Buy	10,086,033 +2,576,383	+34%	+$184M	0.51%	39
2024 Q4	$556M	Buy	+7,509,650	New	+$526M	0.34%	50
2022 Q3	–	Sell	-7,968	Closed	-$758K	–	623
2022 Q2	$758K	Buy	+7,968	New	+$825K	﹤0.01%	547
2021 Q2	–	Sell	-530,008	Closed	-$44.3M	–	694
2021 Q1	$44.3M	Sell	530,008 -2,084,561	-80%	-$176M	0.03%	234
2020 Q4	$239M	Sell	2,614,569 -819,389	-24%	-$68M	0.17%	62
2020 Q3	$274M	Buy	3,433,958 +649,689	+23%	+$50.7M	0.22%	57
2020 Q2	$192M	Sell	2,784,269 -720,502	-21%	-$51.2M	0.17%	61
2020 Q1	$220M	Sell	3,504,771 -11,169,612	-76%	-$805M	0.27%	55
2019 Q4	$1.14B	Sell	14,674,383 -3,662,379	-20%	-$286M	1.15%	26
2019 Q3	$1.34B	Buy	18,336,762 +219,744	+1%	+$15.4M	1.42%	22
2019 Q2	$1.12B	Buy	18,117,018 +825,546	+5%	+$49.9M	1.11%	28
2019 Q1	$1.1B	Buy	17,291,472 +4,955,073	+40%	+$283M	1.1%	28
2018 Q4	$630M	Buy	12,336,399 +8,003,247	+185%	+$405M	0.71%	41
2018 Q3	$251M	Buy	4,333,152 +1,796,205	+71%	+$87.8M	0.23%	56
2018 Q2	$123M	Buy	2,536,947 +810,144	+47%	+$37.8M	0.12%	121
2018 Q1	$80.3M	Buy	1,726,803 +273,366	+19%	+$11.9M	0.08%	183
2017 Q4	$54.6M	Sell	1,453,437 -1,646,691	-53%	-$60.4M	0.05%	251
2017 Q3	$113M	Buy	3,100,128 +180,954	+6%	+$6.9M	0.12%	137
2017 Q2	$115M	Buy	2,919,174 +14,496	+0.5%	+$529K	0.12%	130
2017 Q1	$91.1M	Buy	2,904,678 +527,082	+22%	+$16.5M	0.1%	177
2016 Q4	$74.3M	Buy	+2,377,596	New	+$77M	0.08%	212
2015 Q3	–	Sell	-170,730	Closed	-$4.05M	–	741
2015 Q2	$4.05M	Buy	+170,730	New	+$3.85M	﹤0.01%	554
2013 Q3	–	Hold	0	–	–	–	699
2013 Q2	–	Hold	0	–	–	–	673